
Billionaires Bankroll Cell Rejuvenation Tech as the Latest Gambit to Slow Aging
Start-ups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain
Start-ups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain
By accounting for the additive effect of multiple genetic variants, researchers can develop a system that improves their ability to identify the most vulnerable
A look at apps that predict the chance of infection and illness, depending on what you’re doing and where you are
Clinical studies that group patients according to their molecular profile can make for better and faster drug approval decisions
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account